Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 245.91 USD 0.94%
Market Cap: 36.1B USD
Have any thoughts about
Resmed Inc?
Write Note

Resmed Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Resmed Inc
Accrued Liabilities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Resmed Inc
NYSE:RMD
Accrued Liabilities
$394m
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
13%
Becton Dickinson and Co
NYSE:BDX
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Accrued Liabilities
$2.3B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Accrued Liabilities
$3.5B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
3%
Abbott Laboratories
NYSE:ABT
Accrued Liabilities
$6.5B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
Accrued Liabilities
$867.5m
CAGR 3-Years
21%
CAGR 5-Years
13%
CAGR 10-Years
15%

See Also

What is Resmed Inc's Accrued Liabilities?
Accrued Liabilities
394m USD

Based on the financial report for Sep 30, 2024, Resmed Inc's Accrued Liabilities amounts to 394m USD.

What is Resmed Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
13%

Over the last year, the Accrued Liabilities growth was 6%. The average annual Accrued Liabilities growth rates for Resmed Inc have been 10% over the past three years , 9% over the past five years , and 13% over the past ten years .

Back to Top